Alexander Dane, DO
Dermatology · Largo, FLNPI 1649619982
Payments from drug & device makers
Across 351 payments — averaging $285.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Galderma Laboratories, L.p.$49K
- Sun Pharmaceutical Industries Inc.$34K
- Pfizer$6K
- Almirall LLC$5K
- Vertical Pharmaceuticals, LLC$2K
- Novartis$1K
- plus $3K from 17 others
What the payments were for
- Consulting fees$15,03015%
- Speaking & faculty fees$75,64176%
- Travel & lodging$2,1722%
- Food & beverage$7,2657%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Galderma Laboratories, L.p. | 53 | $49,013 |
| Sun Pharmaceutical Industries Inc. | 102 | $33,663 |
| Pfizer | 7 | $6,008 |
| Almirall LLC | 10 | $5,308 |
| Vertical Pharmaceuticals, LLC | 1 | $2,280 |
| Novartis | 94 | $1,073 |
| Regeneron Healthcare Solutions, Inc. | 8 | $398 |
| AbbVie(2 entities) | 7 | $395 |
| LEO Pharma Inc. | 27 | $291 |
| Genentech USA, Inc. | 13 | $270 |
| Microaire Surgical Instruments LLC | 1 | $208 |
| Incyte Corporation | 4 | $171 |
| Journey Medical Corporation | 2 | $169 |
| E.r. Squibb & Sons, L.L.C. | 1 | $149 |
| Amgen | 3 | $140 |
| Revance Therapeutics, Inc. | 2 | $135 |
| Sanofi | 2 | $132 |
| Kerecis Limited | 5 | $112 |
| Organogenesis Inc. | 3 | $90 |
| Smith+Nephew | 3 | $60 |
| Biowound Solutions, Inc. | 1 | $20 |
| Lilly USA, LLC | 1 | $14 |
| Biofrontera Inc. | 1 | $9 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$100,108 in reported general payments places this provider in the 85th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OdomzoSonidegib Phosphate | 15 | $201,427 |
| Gentamicin Sulfate | 416 | $20,982 |
| Mupirocin | 1,955 | $12,354 |
| Doxycycline Monohydrate | 1,102 | $6,701 |
| Doxycycline Hyclate | 40 | $162 |
| Cephalexin | 35 | $129 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Largo
- Matthew ZookLargo$4.4M
- Michael SherlingLake Worth$78.9M
- Seth FormanTampa$28.2M
- Thomas TaylorTampa$13.6M
- Frank DonHallandale Beach$7.5M
- Francisco FloresMiramar$6.7M
- Hector Wiltz JrMiami$6.4M
- Javier Alonso-LlamazaresCoral Gables$5.6M
- Eduardo WeissHollywood$5.5M
- Francisco KerdelMiami$5.1M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.